Terms: = Prostate cancer AND ACSL3, PRO2194, 2181, ENSG00000123983, O95573, FACL3, ACS3 AND Treatment
8 results:
1. Evaluation of maintenance of the common androgen deprivation therapy with the new antiandrogen therapy in patients with castration-resistant prostate cancer: a systematic review.
Salgado CM; Garcia-Perdomo HA; Reis LO
Int Urol Nephrol; 2022 Jun; 54(6):1187-1192. PubMed ID: 35384583
[TBL] [Abstract] [Full Text] [Related]
2. Long-Chain Acyl-CoA Synthetase 4-Mediated Fatty Acid Metabolism Sustains Androgen Receptor Pathway-Independent prostate cancer.
Ma Y; Zhang X; Alsaidan OA; Yang X; Sulejmani E; Zha J; Beharry Z; Huang H; Bartlett M; Lewis Z; Cai H
Mol Cancer Res; 2021 Jan; 19(1):124-135. PubMed ID: 33077484
[TBL] [Abstract] [Full Text] [Related]
3. Integrative Genomic Analysis of OCT1 Reveals Coordinated Regulation of Androgen Receptor in Advanced prostate cancer.
Takayama KI; Suzuki Y; Yamamoto S; Obinata D; Takahashi S; Inoue S
Endocrinology; 2019 Feb; 160(2):463-472. PubMed ID: 30649323
[TBL] [Abstract] [Full Text] [Related]
4. Pathologically Node-Positive prostate Carcinoma - Prevalence, Pattern of Care and Outcome From a Population-Based Study.
Roy S; Sia M; Tyldesley S; Bahl G
Clin Oncol (R Coll Radiol); 2019 Feb; 31(2):91-98. PubMed ID: 30389262
[TBL] [Abstract] [Full Text] [Related]
5. Targeting Oct1 genomic function inhibits androgen receptor signaling and castration-resistant prostate cancer growth.
Obinata D; Takayama K; Fujiwara K; Suzuki T; Tsutsumi S; Fukuda N; Nagase H; Fujimura T; Urano T; Homma Y; Aburatani H; Takahashi S; Inoue S
Oncogene; 2016 Dec; 35(49):6350-6358. PubMed ID: 27270436
[TBL] [Abstract] [Full Text] [Related]
6. Modulation of androgen receptor signaling in hormonal therapy-resistant prostate cancer cell lines.
Marques RB; Dits NF; Erkens-Schulze S; van Ijcken WF; van Weerden WM; Jenster G
PLoS One; 2011; 6(8):e23144. PubMed ID: 21829708
[TBL] [Abstract] [Full Text] [Related]
7. [prostate cancer management and factors associated with radical prostatectomy in France in 2001].
Jegu J; Tretarre B; Velten M; Guizard AV; Danzon A; Buemi A; Colonna M; Kadi-Hanifi AM; Ganry O; Molinie F; Bara S; Rebillard X; Grosclaude P
Prog Urol; 2010 Jan; 20(1):56-64. PubMed ID: 20123529
[TBL] [Abstract] [Full Text] [Related]
8. Erectile function and quality of life after interstitial radiation therapy for prostate cancer.
Sánchez-Ortiz RF; Broderick GA; Rovner ES; Wein AJ; Whittington R; Malkowicz SB
Int J Impot Res; 2000 Sep; 12 Suppl 3():S18-24. PubMed ID: 11002395
[TBL] [Abstract] [Full Text] [Related]